AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise. The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).
Learn more about the comment process
AMIA responses are arranged by Federal Agency and Congressional Committee.
AMIA urges the U.S. Department of Health and Human Services to advance a risk-based, evidence-driven framework to support responsible AI adoption in clinical care. Key barriers include limited access to representative data, insufficient infrastructure, unclear return on investment, workforce readiness gaps, and weak governance structures. We recommend transparent oversight aligned […]
It is AMIA’s position that prior authorization (PA) must be eliminated to improve patient access to necessary medical care, maintain the healthcare workforce, and reduce the required onerous documentation associated with PA. PA, the onerous process used by health insurance companies, including Medicare Advantage (MA) plans, requires clinicians to obtain […]
It is AMIA’s position that prior authorization (PA) must be eliminated to improve patient access to necessary medical care, maintain the healthcare workforce, and reduce the required onerous documentation associated with PA. PA, the onerous process used by health insurance companies, including Medicare Advantage (MA) plans, requires clinicians to obtain […]
A broad coalition of patient, scientific, and medical organizations urges Congress to swiftly pass a full-year FY2026 appropriations bill funding NIH at $48.7 billion. The letter warns that continuing resolutions and shutdowns delay grants, threaten jobs, and undermine lifesaving research, while supporting Senate provisions on multiyear grants and facilities and […]
AMIA commented on FDA's request for public comment regarding real-world performance evaluation of AI-enabled medical devices. We support lifecycle governance with continuous post-market monitoring to address performance drift across diverse populations and settings. AMIA recommends comprehensive metrics beyond accuracy including clinical outcomes, safety, usability, and equity assessment. We emphasize transparent […]
As one of 450 stakeholders, AMIA calls on Congress for permanent Medicare telehealth legislation. The current lapse affects 4+ million beneficiaries and 30% of providers delivering virtual care, disrupting healthcare innovation and informatics infrastructure. Temporary extensions create instability impeding technology adoption and evidence-based implementation. AMIA supports retroactive payment restoration and […]
The White House Office of Science and Technology Policy (OSTP) issued a Request for Information (RFI) seeking public input on how existing federal laws and regulations may impede the development and adoption of artificial intelligence (AI). In response, AMIA urged regulatory reforms that promote responsible AI use in healthcare while […]
AMIA, along with 75+ medical, scientific, and patient advocacy organizations, sent a letter to Congressional leadership on September 19, 2025, urging swift passage of appropriations funding NIH at $48.7 billion for fiscal year 2026. We expressed alarm over the administration's proposed 40% NIH budget cuts and disruptive policy changes, including […]
AMIA's letter to NIH supporting Option 4 for limiting publication costs in federally funded research. Option 4 would cap publication spending at 0.8% of direct costs or $20,000, whichever is greater. We argue this approach balances fiscal responsibility with research flexibility, particularly important for medical informatics research requiring multi-faceted dissemination […]
Washington, D.C. – It is the position of the American Medical Informatics Association (AMIA) that U.S. health system leaders are accountable for assuring equitable access to care and preventive services grounded in scientific evidence.
AMIA stands firmly with the scientific community in upholding the established gold standard for science, a […]